DSpace at RU >

Browsing by Author Wit, F.W.

Full Text	Issue Date	Title	Author(s)
	2007	Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in Thai HIV-1 infected patients.	Autar, R.S.; Wit, F.W.; Sankote, J., et al
	2010	Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir.	Luin, M. van; Ende, M.E. van der; Richter, C., et al
	2004	Nelfinavir plasma concentrations are low during pregnancy.	Nellen, J.F.; Schillevoort, I.; Wit, F.W., et al
	2005	Nevirapine plasma concentrations and concomitant use of rifampin in patients coinfected with HIV-1 and tuberculosis.	Autar, S.R.; Wit, F.W.; Sankote, J., et al
	2012	No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial.	Grijsen, M.L.; Steingrover, R.; Wit, F.W., et al
	2007	Relationships between drug exposure, changes in metabolic parameters and body fat in HIV-infected patients switched to a nucleoside sparing regimen.	Autar, R.S.; Boyd, M.A.; Wit, F.W., et al
	2009	Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy.	Kesselring, A.M.; Wit, F.W.; Sabin, C.A., et al
	2008	Steady-state nevirapine plasma concentrations are influenced by pregnancy.	Nellen, J.F.; Damming, M.; Godfried, M.H., et al